- $6.1 BnWorld market, 2023
- $12.2 BnProjected, 2033
- 7.2%Growth a year (CAGR)
- 594Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$2.6 Bn
5.2% a year · 42% of the world -
2
China
$490 Mn
8.7% a year · 8% of the world -
3
Canada
$488 Mn
7.2% a year · 8% of the world -
4
Japan
$379 Mn
7.7% a year · 6.2% of the world -
5
Germany
$223 Mn
5.4% a year · 3.7% of the world -
6
France
$168 Mn
6.2% a year · 2.7% of the world -
7
UK
$159 Mn
5.2% a year · 2.6% of the world -
8
Brazil
$153 Mn
8.2% a year · 2.5% of the world -
9
Italy
$146 Mn
6.7% a year · 2.4% of the world -
10
Ecuador
$122 Mn
7.8% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Spain
EgyptProbiotic Supplements for Gut Health by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 22,074 papers since 2021
- Critical advances and translational bottlenecks of gut microbiota-gut-brain axis targeted therapy for neurodegenerative and neurodevelopmental disorders. Journal of neuroimmunology, 2026
- Temporal Dynamics of the Faecal Microbiota and Physiological Responses to Phytobiotics and Organic Acids in Broiler Chickens. Journal of animal physiology and animal nutrition, 2026
- From Phenotype to Phylogenomics: Evolution of Lactobacillaceae Taxonomy, the 2020 Reclassification and its Technological and Regulatory Implications. Probiotics and antimicrobial proteins, 2026
- Investigating the Effect of Synbiotic Supplementation on Inflammatory Indices in Critically Ill Septic Children: a Triple Blind Randomized Controlled Trial. Probiotics and antimicrobial proteins, 2026
- From Dysbiosis to Vascular Disease: the Gut Microbiota in Type 2 Diabetes and Atherosclerosis. Current atherosclerosis reports, 2026
Compare Probiotic Supplements for Gut Health side by side
Key companies in Probiotic Supplements for Gut Health
BioGaia
Danone
Farmaceutica
International Flavors & Fragrances
Lallemand
Meiji Holdings Co Ltd
Nestle
Probi
Yakult Honsha Co Ltd
Quick answers
How big is the Probiotic Supplements for Gut Health market?
The world Probiotic Supplements for Gut Health market was worth about $6.1 Bn in 2023 and is projected to reach $12.2 Bn by 2033, growing 7.2% a year (CAGR).
Which country has the largest Probiotic Supplements for Gut Health market?
The US is the largest of the 24 countries we cover, at $2.6 Bn in 2023. India grows fastest, at 10.2% a year.
How many clinical trials are running in Probiotic Supplements for Gut Health?
ClinicalTrials.gov lists 594 active trials worldwide (recruiting, about to start or running), most of them in China, as of 10 Nov 2026.
How much research is published on Probiotic Supplements for Gut Health?
PubMed lists about 22,074 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.